Please login to the form below

Not currently logged in

FDA approves new version of diabetes drug

Japanese pharmaceutical company Daiichi Sankyo's diabetes treatment Welchol has been approved in a new formulation by the US Food and Drug Administration

Japanese pharmaceutical company Daiichi Sankyo has received US Food and Drug Administration (FDA) approval for a new formulation of its liquid diabetes drug Welchol that can be mixed with fruit juice and diet sodas.

Welchol was first approved in 2009 and was to be mixed with water. The drug lowers blood sugar in patients diagnosed with type 2 diabetes.

Meanwhile Daiichi Sankyo is replacing its legacy, on-premise customer relationship management (CRM) system with Veeva CRM in the UK. The company will deploy Veeva CRM to all of its commercial teams in the UK.

Cloud-based, Veeva CRM requires no hardware or software to purchase, scale or maintain. In addition, Veeva customers benefit from free, automatic upgrades. Changes can be made to the system without user retraining or additional third-party costs.

26th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....